Shell Asset Management’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1
| Closed | – | – | 1265 |
|
|
2024
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1268 |
|
|
2024
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1253 |
|
|
2024
Q1 | $0 | Sell |
1
-59,301
| -100% | – | ﹤0.01% | 1267 |
|
|
2023
Q4 | $222K | Sell |
59,302
-17,897
| -23% | -$67K | 0.01% | 815 |
|
|
2023
Q3 | $164K | Buy |
77,199
+73,456
| +1,962% | +$156K | 0.01% | 966 |
|
|
2023
Q2 | $18K | Sell |
3,743
-21
| -0.6% | -$101 | ﹤0.01% | 1261 |
|
|
2023
Q1 | $21K | Sell |
3,764
-13
| -0.3% | -$73 | ﹤0.01% | 1231 |
|
|
2022
Q4 | $38K | Sell |
3,777
-765
| -17% | -$7.7K | ﹤0.01% | 1291 |
|
|
2022
Q3 | $102K | Sell |
4,542
-1,190
| -21% | -$26.7K | ﹤0.01% | 1226 |
|
|
2022
Q2 | $142K | Buy |
5,732
+9
| +0.2% | +$223 | ﹤0.01% | 1205 |
|
|
2022
Q1 | $222K | Sell |
5,723
-848
| -13% | -$32.9K | 0.01% | 1143 |
|
|
2021
Q4 | $384K | Buy |
6,571
+36
| +0.6% | +$2.1K | 0.01% | 1012 |
|
|
2021
Q3 | $387K | Sell |
6,535
-290
| -4% | -$17.2K | 0.01% | 978 |
|
|
2021
Q2 | $592K | Buy |
+6,825
| New | +$592K | 0.01% | 843 |
|